Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension

被引:8
作者
Brassard, P [1 ]
Bourgault, C
Brophy, J
Kezouh, A
Rainville, B
Xhignesse, M
Suissa, S
机构
[1] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, 687 Pine Ave W,Ross 4-29, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ H3A 1A1, Canada
[4] Univ Sherbrooke, Ctr Hosp, Sherbrooke, PQ J1K 2R1, Canada
关键词
D O I
10.1016/S0002-8703(03)00087-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Given the premise that certain bacteria (such as Chlamydia pneumoniae) may play a role in the etiology of atherosclerosis, subjects treated with antibiotics that have antibacterial activity against C pneumoniae may be at lower risk for the development of an acute myocardial infarction (MI) than untreated subjects. Methods A case-control design, nested within a cohort of 29,937 elderly subjects in whom antihypertensive therapy was initiated (1982-1995) was used, in which each subject who was hospitalized with a primary discharge diagnosis of MI between 1987 and 1995 (n =1047) was matched on calendar time to 5 randomly selected control subjects for exposure contrasts. Conditional logistic regression analyses were conducted to adjust for predisposing factors for MI. Results Although no clear consistent effect of antibiotics use was found in relation to MI, a trend was observed for a decreased risk of acute MI in patients receiving a prescription for antichlamydial antibiotics in the preceding 3 months (odds ratio 0.68, 95% CI 0.46-1.00). Antibiotics without antichlamydial activity showed no benefit in MI risk. Conclusion The beneficial effect of certain antichlamydial antibiotics in reducing the risk of MI cannot be excluded on the basis of this representative cohort of elderly patients in a routine clinical care setting. Larger prospective studies are required to confirm the usefulness of antibiotics in the primary prevention of MI.
引用
收藏
页数:8
相关论文
共 20 条
  • [1] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study
    Anderson, JL
    Muhlestein, JB
    Carlquist, J
    Allen, A
    Trehan, S
    Nielson, C
    Hall, S
    Brady, J
    Egger, M
    Horne, B
    Lim, T
    [J]. CIRCULATION, 1999, 99 (12) : 1540 - 1547
  • [2] Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts
    Bartels, C
    Maass, M
    Bein, G
    Malisius, R
    Brill, N
    Bechtel, JFM
    Sayk, F
    Feller, AC
    Sievers, HH
    [J]. CIRCULATION, 1999, 99 (07) : 879 - 882
  • [3] Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction
    Choussat, R
    Montalescot, G
    Collet, JP
    Jardel, C
    Ankri, A
    Fillet, AM
    Thomas, D
    Raymond, J
    Bastard, JP
    Drobinski, G
    Orfila, J
    Agut, H
    Thomas, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (04) : 379 - 384
  • [4] Chronic infections and coronary heart disease: is there a link?
    Danesh, J
    Collins, R
    Peto, R
    [J]. LANCET, 1997, 350 (9075) : 430 - 436
  • [5] Risk factors for coronary heart disease and infection with Helicobacter pylori:: meta-analysis of 18 studies
    Danesh, J
    Peto, R
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7138) : 1130 - 1132
  • [6] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
    Danesh, J
    Whincup, P
    Walker, M
    Lennon, L
    Thomson, A
    Appleby, P
    Gallimore, JR
    Pepys, MB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255): : 199 - 204
  • [7] Gupta S, 1997, CIRCULATION, V96, P404
  • [8] Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
    Gurfinkel, E
    Bozovich, G
    Daroca, A
    Beck, E
    Mautner, B
    [J]. LANCET, 1997, 350 (9075) : 404 - 407
  • [9] ANTIMICROBIAL SUSCEPTIBILITY AND THERAPY OF INFECTIONS CAUSED BY CHLAMYDIA-PNEUMONIAE
    HAMMERSCHLAG, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 1873 - 1878
  • [10] Herings Ron M. C., 2000, Pharmacoepidemiology and Drug Safety, V9, pS145